Results 61 to 70 of about 57,111 (301)

The phospho–caveolin-1 scaffolding domain dampens force fluctuations in focal adhesions and promotes cancer cell migration

open access: yesMolecular Biology of the Cell, 2017
The caveolin scaffolding domain mediates the promigratory activity of Src-phosphorylated (on Y14) caveolin-1 and, specifically, regulation of vinculin tension in focal adhesions.
Fanrui Meng   +8 more
semanticscholar   +1 more source

Oxldl Upregulates Caveolin-1 Expression in Macrophages: Role for Caveolin- 1 in the Adhesion of Oxldl-Treated Macrophages to Endothelium

open access: yes, 2011
Caveolin-1, a principle component of caveolae, is present in several cell types known to play an important role in the development of atherosclerosis.
吳造中;王淑慧;管奕奕;曾維功;陳明豐;吳建春;陳玉怜   +1 more
core   +1 more source

Caveolin as a Potential Drug Target for Cardiovascular Protection

open access: yesFrontiers in Physiology, 2012
Caveolae and caveolin are key players in a number of disease processes. Current research indicates that caveolins play a significant role in cardiovascular disease and dysfunction.
Stephanie L Sellers   +2 more
doaj   +1 more source

SnapShot: Caveolae, Caveolins, and Cavins

open access: yesCell, 2013
Caveolae, submicroscopic bulb-shaped plasma membrane pits, are an abundant feature of many mammalian cells (Parton and del Pozo, 2013). Caveolae and the major proteins of caveolae, caveolins (Rothberg et al., 1992), and cavins (Hill et al., 2008), are linked to a number of human diseases such as muscular dystrophy, cardiomyopathy, and lipodys -trophy ...
Ariotti, Nicholas, Parton Robert G.
openaire   +5 more sources

Association/Dissociation of Caveolin-1 and Nitric Oxide Synthase in Preserving Renal Medulla Function during Hemorrhage and Aging [PDF]

open access: yes, 2021
Background: Caveolin-1 is a negative regulator of endothelial nitric oxide synthase (eNOS), as its interaction and binding suppress the activityof eNOS by making caveolin–eNOS complex.
Balaszczuk, Ana María   +4 more
core   +1 more source

Synapsin-Promoted Caveolin-1 Overexpression Maintains Mitochondrial Morphology and Function in PSAPP Alzheimer’s Disease Mice

open access: yesCells, 2021
Mitochondrial dysfunction plays a pivotal role in the Alzheimer’s Disease (AD) pathology. Disrupted mitochondrial dynamics (i.e., fusion/fission balance), which are essential for normal mitochondria structure and function, are documented in AD.
Shanshan Wang   +5 more
doaj   +1 more source

Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

open access: yesJournal of Biological Chemistry, 2001
Caveolin-1 is the principal structural protein of caveolae membranes in fibroblasts and endothelia. Recently, we have shown that the human CAV-1 gene is localized to a suspected tumor suppressor locus, and mutations in Cav-1 have been implicated in human
B. Razani   +16 more
semanticscholar   +1 more source

Modulation of miR‐23b Wnt/β‐catenin Axis Strengthens Endothelial Barrier Properties

open access: yesAdvanced Science, EarlyView.
Early blood‐brain barrier (BBB) disruption contributes to stroke and CNS disease pathology. miR‐23b was identified as a regulator of BBB integrity in brain endothelial cells. Inhibition of miR‐23b enhanced barrier‐associated properties, promoted repair‐related signaling, and reduced BBB leakage in experimental stroke models, supporting further ...
Victor Anthony Martinez   +16 more
wiley   +1 more source

Caveolin-1 Expression Is Significantly Associated with Drug Resistance and Poor Prognosis in Advanced Non-Small Cell Lung Cancer Patients Treated with Gemcitabine-Based Chemotherapy

open access: yes, 2011
Caveolin-1 was up-regulated in different drug-resistant cancer cell tines and was suggested to confer drug resistance by different mechanisms. However, the relation of caveolin-1 expression and the clinical response to chemotherapy and prognosis in non ...
何肇基;郭頌鑫;黃佩欣;黃馨儀;楊志新;楊泮池   +1 more
core   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy